Patients Drug And Other Therapy:
Patients’ intensive care needs, oxygen needs, and mechanical ventilation status, mask oxygen needs and CPAP needs were evaluated. Hydroxychloroquine, favipiravir, dexamethasone, and antibiotheraphy for secondary infection or prophylaxis were used in medical treatment. Worsening in symptoms, laboratory results such as dramatic elevation in CRP, ferritin and D-dimer levels and lung involvent in CT were regarded as an indication for hospitalization. Transplant patients with COVID-19 patients were treated in a specific clinic for COVID-19 patients outside of transplant unit. Treatment was arranged by clinicians in COVID-19 clinic with the consultation to nephrologist and transplant surgeon. Immunosuppresors such as calcineurin inhibitors, anti-metabolite agents, and steroids were revised. Steroid dose (Prednisolone) was doubled (from 5 mg/day to 10 mg/day). Inflamation parameters (CRP, procalcitonine), kidney function tests and immunosupressors were closely monitored. Immunosuppressors except to steroid were discontinued in the unresponsive patients to treatment.